Broad protection and respiratory immunity of dual mRNA vaccination against SARS-CoV-2 variants
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Broad protection and respiratory immunity of dual mRNA vaccination against SARS-CoV-2 variants ; volume:9 ; number:1 ; day:4 ; month:9 ; year:2024 ; pages:1-12 ; date:12.2024
npj vaccines ; 9, Heft 1 (4.9.2024), 1-12, 12.2024
- Urheber
-
Hajnik, Renee L.
Plante, Jessica A.
Reddy Bonam, Srinivasa
Rafael, Grace H.
Liang, Yuejin
Hazell, Nicholas C.
Walker, Jordyn
Reyna, Rachel A.
Walker, David H.
Alameh, Mohamad-Gabriel
Weissman, Drew
Weaver, Scott C.
Plante, Kenneth S.
Hu, Haitao
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41541-024-00957-2
- URN
-
urn:nbn:de:101:1-2411202140050.050839296518
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hajnik, Renee L.
- Plante, Jessica A.
- Reddy Bonam, Srinivasa
- Rafael, Grace H.
- Liang, Yuejin
- Hazell, Nicholas C.
- Walker, Jordyn
- Reyna, Rachel A.
- Walker, David H.
- Alameh, Mohamad-Gabriel
- Weissman, Drew
- Weaver, Scott C.
- Plante, Kenneth S.
- Hu, Haitao
- SpringerLink (Online service)
Ähnliche Objekte (12)
Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection
A COVID-19 model incorporating variants, vaccination, waning immunity, and population behavior
Virus-specific CD8+ T cell immunity in acute vs. chronic infection and upon mRNA vaccination
Boosting compromised SARS-CoV-2-specific immunity with mRNA vaccination in liver transplant recipients
Predominantly defective CD8+ T cell immunity to SARS-CoV-2 mRNA vaccination in lung transplant recipients
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants
SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations
Immune Responses 6 Months After mRNA-1273 COVID-19 Vaccination and the Effect of a Third Vaccination in Patients with Inborn Errors of Immunity
Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years
Genetic variants associated mRNA stability in lung
mRNA vaccines enhance neutralizing immunity against SARS-CoV-2 variants in convalescent and ChAdOx1-primed subjects
Bilateral Optic Neuritis after COVID-19 mRNA Vaccination
Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection
A COVID-19 model incorporating variants, vaccination, waning immunity, and population behavior
Virus-specific CD8+ T cell immunity in acute vs. chronic infection and upon mRNA vaccination
Boosting compromised SARS-CoV-2-specific immunity with mRNA vaccination in liver transplant recipients
Predominantly defective CD8+ T cell immunity to SARS-CoV-2 mRNA vaccination in lung transplant recipients
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants
SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations
Immune Responses 6 Months After mRNA-1273 COVID-19 Vaccination and the Effect of a Third Vaccination in Patients with Inborn Errors of Immunity
Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years
Genetic variants associated mRNA stability in lung
mRNA vaccines enhance neutralizing immunity against SARS-CoV-2 variants in convalescent and ChAdOx1-primed subjects
Bilateral Optic Neuritis after COVID-19 mRNA Vaccination
Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection
A COVID-19 model incorporating variants, vaccination, waning immunity, and population behavior
Virus-specific CD8+ T cell immunity in acute vs. chronic infection and upon mRNA vaccination
Boosting compromised SARS-CoV-2-specific immunity with mRNA vaccination in liver transplant recipients
Predominantly defective CD8+ T cell immunity to SARS-CoV-2 mRNA vaccination in lung transplant recipients
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants
SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations
Immune Responses 6 Months After mRNA-1273 COVID-19 Vaccination and the Effect of a Third Vaccination in Patients with Inborn Errors of Immunity
Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years
Genetic variants associated mRNA stability in lung
mRNA vaccines enhance neutralizing immunity against SARS-CoV-2 variants in convalescent and ChAdOx1-primed subjects